Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
These work through different mechanisms than GLP-1 receptor agonists
Stopping Semaglutide or Tirzepatide is safe and common, though you may experience increased appetite and weight gain
A good health blog should not just inform
Its essential to inform both your prescribing physician and mental health provider about all medications youre taking, including GLP-1 inhibitors, to ensure comprehensive care and monitoring
References Aronne, L.J
If any apply, the medication should not be prescribed: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Known serious hypersensitivity to the active medication or to a related incretin-receptor agonist Clinical precautions that prompt careful screening These are not absolute contraindications on the FDA label, but they meaningfully change the risk-benefit conversation
